JOULWAN GEORGE A 4
4 · Emergent BioSolutions Inc. · Filed Nov 9, 2017
Insider Transaction Report
Form 4
JOULWAN GEORGE A
Director
Transactions
- Sale
Common Stock
2017-11-07$41.24/sh−3,946$162,733→ 30,377 total - Exercise/Conversion
Common Stock
2017-11-07$15.97/sh+3,946$63,018→ 34,323 total - Exercise/Conversion
Common Stock
2017-11-07$18.64/sh+10,305$192,085→ 40,682 total - Exercise/Conversion
Employee Stock Option (Right to buy)
2017-11-07−3,946→ 0 totalExercise: $15.97Exp: 2020-07-17→ Common Stock (3,946 underlying) - Sale
Common Stock
2017-11-07$41.24/sh−10,305$424,978→ 30,377 total - Exercise/Conversion
Employee Stock Option (Right to buy)
2017-11-07−10,305→ 0 totalExercise: $18.64Exp: 2021-05-22→ Common Stock (10,305 underlying)
Footnotes (3)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.45, inclusive.
- [F2]Consists of an option granted under the company's stock incentive plan as amended and restated.
- [F3]The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.